Michael B. Johnson is an experienced pharmaceutical and biotech commercial executive currently serving as the Senior Vice President and Chief Commercial Officer at EVERSANA since 2024. With a proven track record in global product launches across various therapeutic areas, they previously held leadership roles at Mallinckrodt Pharmaceuticals and Bristol Myers Squibb, focusing on commercial strategy and brand management. Michael's educational background includes a B.S. in Marketing and an M.S. in Management, along with specialized training in Leadership and Negotiation from Columbia University. They also contribute to the DMAX Foundation, supporting mental health initiatives for youth.
This person is not in the org chart
This person is not in any teams
This person is not in any offices